Below is a report that DML News gives a 4 OUT OF 4 STARS trustworthiness rating. We base this rating on the following criteria:

  • Provides named sources
  • Reported by more than one notable outlet
  • Does not insert opinion or leading words
  • Includes supporting video, direct statements, or photos

Click here to read more about our rating system.

As the most reliable and balanced news aggregation service on the internet, DML News offers the following information published by WASHINGTONEXAMINER.COM:

Drug companies will be unable to game a requirement to give states large prescription rebates through Medicaid under a law the Trump administration implemented Thursday.

The guidance closes a loophole that drug companies exploited by making superficial changes to existing drugs to inflate their costs and thus pay states less than they owed. The changes allowed drug companies to treat the medicines as new drugs and change the rebate calculation.

The article goes on to state the following:

“This is the kind of abusive behavior from drug companies that this administration will not tolerate,” said Health and Human Services Secretary Alex Azar in announcing the change at the American Legislative Exchange Council in New Orleans.

The rules around these types of drugs, known as “line extensions,” were changed under legislation President Trump signed into law in February.

Drug companies are required by law to give rebates to states to cover people under Medicaid, who are low-income

To weigh in on this information provided by WASHINGTONEXAMINER.COM, engage in our LIVE CHAT below. Scroll down.

LEAVE A REPLY

Please enter your comment!
Please enter your name here